Cafepharma Today

June 26 2025 - Altimmune's stock sinks on mixed phase 2 MASH results for GLP-1 drug
Altimmune's stock sinks on mixed phase 2 MASH results for GLP-1 drug
Incyte waves goodbye to longtime CEO Hervé Hoppenot as new appointment raises M&A hopes
Lilly to launch Mounjaro pen in India to compete with Novo's weight-loss drug Wegovy
RFK Jr.'s vaccine advisors recommend RSV antibodies for infants
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Sarepta Therapeutics: Stock Rising Too Far, Too Fast?
Seeking Alpha
Tuesday, September 4, 2012 - 11:11am
tags:
Sarepta, eteplirsen, Duchenne Muscular Dystrophy
CEO Gaffe of the Week: Bristol-Myers Squibb -- Again!
Motley Fool
Tuesday, September 4, 2012 - 11:09am
tags:
Lamberto Andreotti, Bristol-Myers Squibb
Four Important Biotech Stocks Targeting Unmet Needs
Motley Fool
Tuesday, September 4, 2012 - 11:08am
tags:
Neurocrine Biosciences, Acorda Therapeutics, Amarin, Nektar
3 Things to Watch in the Pharmaceutical Sector Right Now
Motley Fool
Tuesday, September 4, 2012 - 11:05am
tags:
Amylin, Bristol-Myers Squibb, Arena Pharmaceuticals, Pfizer
A Good Start on the Biosimilar Front
Motley Fool
Tuesday, September 4, 2012 - 11:04am
tags:
biosimilars, Teva Pharmaceuticals, Amgen, Watson Pharmaceuticals, Momenta, Baxter International, FDA, Affordable Care Act
Valeant To Acquire Medicis for $2.6 Billion
Forbes
Tuesday, September 4, 2012 - 10:56am
tags:
Valeant Pharmaceuticals, Medicis, M&A
China Biotech In Review: Sino Biological Partners With Life Technologies
Seeking Alpha
Tuesday, September 4, 2012 - 10:54am
tags:
Sino Biological Partners, Life Technologies, China
The $47 Billion Hole in Pharma's Near-Term Future
Forbes
Tuesday, September 4, 2012 - 10:53am
tags:
Pfizer, Merck, Eli Lilly, Bristol-Myers Squibb, Novo Nordisk, emerging markets, generics
ConvaTec to buy 180 Medical Holdings for $321 million
Reuters
Tuesday, September 4, 2012 - 10:51am
tags:
ConvaTec, M&A, 180 Medical Holdings
Game Changer for the Human Genome Sector?
Minyanville
Friday, August 31, 2012 - 1:04pm
tags:
stem cells, ALS, Neuralstem, Pfizer, GSK, JNJ, GE Healthcare, Arthersys
FDA approves Ironwood, Forest Labs bowel drug
Yahoo/AP
Friday, August 31, 2012 - 12:58pm
tags:
FDA, Ironwood, Forest Labs, Linzess
Sarepta rallies for second consecutive day
Marketwatch
Friday, August 31, 2012 - 12:55pm
tags:
Sarepta, eteplirsen, Duchenne Muscular Dystrophy
5 Pharmaceutical Companies With EMA Catalysts During The Next 3-12 Months
Seeking Alpha
Friday, August 31, 2012 - 12:51pm
tags:
Affymax, Arena Pharmaceuticals, Avanir, Curis, Dendreon
Pfizer licenses cancer immune therapy from VLST, which is prepared to start mid-stage testing
Yahoo/AP
Friday, August 31, 2012 - 12:34pm
tags:
Pfizer, immune therapy, VLST, CP-870, 893
Generics Will Drive Mylan Higher By 2013
Seeking Alpha
Friday, August 31, 2012 - 12:33pm
tags:
Mylan, generics, Bristol-Myers Squibb, Merck, Pfizer, Teva Pharmaceuticals
J&J Will Pay $181 Million To Settle Risperdal Ad Claims
Bloomberg
Friday, August 31, 2012 - 12:29pm
tags:
Risperdal, JNJ, settlements, advertising
Pfizer Loses Bid To Dismiss Fen-Phen Lung Ailment Suits
Bloomberg
Friday, August 31, 2012 - 12:28pm
tags:
Pfizer, Fen-Phen
This Drug Is Getting Some Negative ATTENTION: ArQule's Tivantinib
Motley Fool
Friday, August 31, 2012 - 12:27pm
tags:
tivantinib, Arqule, lung cancer, Tarceva, Roche, Astellas
Zalicus: Ready To Rebound
Seeking Alpha
Friday, August 31, 2012 - 12:24pm
tags:
Zalicus, Exalgo, Z160, Synavive, Prednisporin, Z944
FDA warns against use of Pfizer's Revatio in children
Reuters
Friday, August 31, 2012 - 12:20pm
tags:
FDA, Pfizer, Revatio, PAH, pulmonary arterial hypertension

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

The Continuing Crisis, Part XVI: Get the Hell Out of Your Building
In the Pipeline
Tiny Crystals from Small Extracts
In the Pipeline
Hexanitrogen
In the Pipeline
Stir Bars Can't Be Ignored
In the Pipeline
AI Effects on Drug Patents
In the Pipeline
Mirror Morphine
In the Pipeline
Vaccine Advice, Vandalized
In the Pipeline
Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.